Siemens Healthineers has received a license from Health Canada for the sale of its Mammomat Revelation digital mammography system.
Mammomat Revelation includes the InSpect integrated specimen imaging tool and the HD Breast Biopsy feature for automated imaging and review of potential lesions in the breast. Siemens also secured U.S. Food and Drug Administration (FDA) clearance for Mammomat Revelation in early 2018.